First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma

Cancer

Volumn 104, Issue 4, 2005, Pages 763-770

  Westermann, Anneke M ^a   Jones, Ellen L ^b   Schem, Baard Christian ^c   Van Der Steen Banasik, Elzbieta M ^d   Koper, Peter ^e   Mella, Olav ^c   Uitterhoeve, Apollonia L J ^a   De Wit, Ronald ^e   Van Der Velden, Jacobus ^a   Burger, Curt ^e   Van Der Wilt, Clasina L ^f   Dahl, Olav ^c   Prosnitz, Leonard R ^b   Van Der Zee, Jacoba ^e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Arnhems Radiotherapeutisch Instituut   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

Cervical carcinoma; Chemotherapy; Combined modality treatment; Hyperthermia; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; SEROTONIN ANTAGONIST; STEROID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FAT NECROSIS; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NETHERLANDS; NORWAY; PAIN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; TOXICITY; TREATMENT OUTCOME; UNITED STATES; UTERINE CERVIX CARCINOMA; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; RADIOTHERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 23444460964     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21128     Document Type: Article

References (25)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
2. Rose PG, Bundy BN, Watkins J, et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
3. Peters WA III, Liu PY, Barrett R, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
4. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340:1137-1143.
5. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky Stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
6. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage HB-FVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
7. National Cancer Institute. Concurrent chemoradiation for cervical cancer [clinical announcement]. Bethesda: National Cancer Institute, 1999.
8. Overgaard J. Fractionated radiation and hyperthermia. Experimental and clinical studies. Cancer. 1981;48:1116-1123.
9. van der Zee J, González-Gonźlez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet. 2000;355: 1119-1125.
10. Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in Stage IIIB cervical carcinoma. Int J Hyperthermia. 2001;17: 97-105.
11. Urano M, Kahn J, Majima H, et al. The cytotoxic effect of CDDP on cultured CHO cells at elevated temperature: Arrhenius plot analysis. Int J Hyperthermia. 1990;6:581-590.
12. Rietbroek RC, Schilthuis MS, Bakker PJM, et al. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with previously irradiated recurrent carcinoma of the uterine cervix. Cancer. 1997;79:935-943.
13. de Wit R, van der Zee J, van der Burg ME, et al. A Phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer. 1999; 80:1387-1391.
14. Herman TS, Teicher BA. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Res. 1988;48: 2693-2697.
15. Herman TS, Jochelson MS, Teicher BA, et al. A Phase I/II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys. 1989;17:1273-1279.
16. Jones EL, Samulski TV, Dewhirst MW, et al. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer. 2003;98;2:277-282.
17. Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8:1981-1997.
18. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
19. Orton CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 2001;49:183-189.
20. Simon R. Optimal two-stage designs for Phase II clinical trials. Control Clin Trials. 1989;10:1-10.
21. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966-972.
22. Grogan M, Thomas GM, Melamed I, et al. The importance of haemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999;86:1528-1536.
23. Rose PG, Bundy BN. Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol. 2002;20:891-893.
24. Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys. 1995;33:887-899.
25. Hand JW, Machin D, Vernon CC, et al. Analysis of thermal parameters obtained during Phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia. 1997;13:343-364.